AIDS Research and Human Retroviruses · 1991 · 29 citations · 22 references
Life SciencesImmunologyMolecular BiologyMolecular VirologyVaccinologyVirologyAntibody PurificationAntiviral ImmunityHumoral ImmunityViral InfectionsViral TranscriptionViral VaccinesAntibodiesAntibody-mediated Virus NeutralizationHiv Envelope Glycoprotein AntigensHumoral Immune DefenseImmunoaffinity PurificationLectin Affinity ChromatographyNeutralizing Antibody AssaysViral Antigen Recognition
A recombinant vaccinia virus in which the transcription of the human immunodeficiency virus type 1 (BRU isolate) env gene is driven by the 11K late vaccinia promoter yields about 10-fold higher amounts of gp160 env protein upon infection of monkey cells than does a recombinant in which gp160 is expressed using the 7.5K early-late promoter. The gp160 was purified from detergent lysates of infected cells by lentil lectin affinity chromatography followed by immunoaffinity chromatography, and was obtained in yields of 1-2 mg/10(9) cells of material estimated to be about 70% pure. Pairs of rabbits were immunized with purified gp160 using either one of five different adjuvants or an immunostimulating complex. In all cases a substantial humoral immune response was obtained after boosting, including an activity that neutralized the homologous (BRU) isolate of HIV-1. In some cases, this activity also neutralized two distantly related isolates, SF2 and MN.
22
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Brør Morein, Bo Sundquist, Stefan Höglund et al. · Nature · 1984 · 709 citations